M&A Deal Summary |
|
---|---|
Date | 2016-05-23 |
Target | XenoPort |
Sector | Life Science |
Buyer(s) | Arbor Pharmaceuticals |
Deal Type | Add-on Acquisition |
Deal Value | 467M USD |
Advisor(s) | Centerview Partners (Financial) Weil Gotshal & Manges (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Arbor Pharmaceuticals is a specialty pharmaceutical company with a diversified portfolio of branded products across multiple therapeutic areas for the cardiovascular, pediatric, and hospital markets as well as generic products through its Wilshire division. Arbor Pharmaceuticals is based in Atlanta, Georgia.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (California) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2016) | 1 of 1 |
Size (of disclosed) | 1 of 1 |